Evidence map›Paper›PMID 37684636›Full record

ArticleAddiction science & clinical practice2023

Drug policies' sensitivity towards women, pregnancy, and motherhood: a content analysis of national policy and programs from nine countries and their adherence to international guidelines.

Abhishek Ghosh, Dijana Jerkovic, Liljana Aleksandar Ignjatova, Carla Bruguera, Dalia I Ibrahim, Katarzyna Okulicz-Kozaryn, J Maphisa Maphisa, Thomas F Martinelli, Ana Neto, Joana Canedo and 1 more

Abstract read
In one paragraph

Article in Addiction science & clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Abhishek GhoshDepartment of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Dijana JerkovicDepartment of Criminology, Faculty of Education and Rehabilitation Sciences, University of Zagreb, Zagreb, Croatia. dijana.jerkovich@gmail.com.ORCID http://orcid.org/0000-0001-6163-614X
Liljana Aleksandar IgnjatovaFaculty of Medicine Skopje, University of St. Cyril and Methodius Skopje, Skopje, Republic of North Macedonia.
Carla BrugueraProgram on Substance Abuse, Public Health Agency of Catalonia, Barcelona, Spain.
Dalia I IbrahimMental Health and Addiction Treatment-Ministry of Health and Population-Egypt, Cairo, Egypt.
Katarzyna Okulicz-KozarynInstitute of Mother and Child, Warsaw, Poland.
J Maphisa MaphisaDepartment of Psychology, University of Botswana, Gaborone, Botswana.
Thomas F MartinelliProgram Drugs, Trimbos-Institute, Utrecht, The Netherlands.
Ana NetoUnidade de Alcoologia de Lisboa, DICAD, ARSLVT, IP, Lisbon, Portugal.
Joana CanedoDevelopment Studies (ICS-IUL, FCT), EuroNPUD, GAT Manas, Lisbon, Portugal.
Rebecca GordonAddictions Unit, Psychiatry Department, Institute of Neurosciences, Hospital Clínic de Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesSubstance use in women is associated with unique psycho-social and physical vulnerabilities and poses complex challenges during pregnancy and motherhood. Gender-sensitive drug policy which considers the needs of women and their children could address these concerns. The objectives of this study were: (1) to systematically explore national-level drug policies' sensitivity and responsiveness to women, pregnant women, and children; and (2) to examine the adherence of drug policies with international guidelines for gender sensitivity in drug policy.

methodsThe research team was diverse professional backgrounds and nine countries. A summative content analysis of national drug policy documents, action plans, and strategies was performed. Specific documents focusing on women, pregnancy, and children were analysed. Specific themes and how frequently they appeared in the documents were identified. This quantification was an attempt to explore usage indicating the relative focus of the policies. A thematic map was developed to understand how national-level drug policies conceive and address specific concerns related to women who use drugs. We adapted the UNODC checklist for gender mainstreaming to assess policies' adherence to international guidelines.

resultsTwenty published documents from nine countries were reviewed. The common themes that emerged for women, pregnancy, and children were needs assessment, prevention, treatment, training, supply reduction, and collaboration and coordination. Custody of children was a unique theme for pregnant women. Specific psycho-social concerns and social reintegration were special themes for women, whereas legislation, harm reduction, research, and resource allocation were children-specific additional themes. For women-specific content analysis, special issues/concerns in women with drug misuse, need assessment, and prevention were the three most frequent themes; for the children-specific policies, prevention, training, and treatment comprised the three most occurring themes. For pregnant women/pregnancy, prevention, treatment, and child custody were the highest occurring themes. According to ratings of the countries' policies, there is limited adherence to international guidelines which ensure activities are in sync with the specific needs of women, pregnant women and their children.

conclusionOur analysis should help policymakers revise, update and adapt national policies to ensure they are gender-responsive and address the needs of women, pregnant women and their children.

Indexed as

Drug UsersSubstance-Related DisordersChildFemaleHarm ReductionHumansPregnancyPublic Policy

Identifiers

PMID37684636
PMCPMC10485932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.